Abstract
Although the chain of events leading to asthma is highly complex, the dysregulated production of type 2 cytokines, notably IL-4 and IL-5, by allergen-specific T cells, has emerged as an important causative factor [1, 2]. The symptoms of allergic asthma, including reversible airways occlusion and airways hyperreactivity (AHR), correlate with a local infiltration of the airways mucosa by inflammatory cells, whose recruitment and activation is influenced by IL-3, IL-4, IL-5, granulocyte-macrophage colony stimulating factor and other chemotactic agents produced by activated Th2 cells [3-6]. Indeed, the severity of disease appears to correlate with the degree of airways inflammation and the level of local Th2 cell activity [7, 8]. The molecular and cellular mechanisms underlying the presence of large numbers of Th2 cells in allergic airways remain to be resolved, however their products appear to have profound and specific effects in promoting allergic disease. IL-5, for example, regulates all stages of the development of eosinophils, which are consistently the predominant leukocyte population in the inflammatory infiltrate of asthmatics [5]. IL-4 modulates mast cell activity [4] and, through its influence on Ig class switching, regulates the production of IgE [3] which may specifically sensitize inflammatory cells implicated in allergic airways disease, including mast cells, eosinophils, basophils and macrophages. This leads to the release of inflammatory substances including histamine, leukotrienes, platelet-activating factor, cationic proteins and chemokines which may, in turn, augment the inflammatory process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Leung DYM, Martin RJ, Szefler SJ, Sher ER, Ying S, Kay AB, Hamid Q (1995) Dys-regulation of interleukin 4, interleukin 5 and interferon gamma gene expression in steroid-resistant asthma. J Exp Med 181: 33–40
Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB (1992) Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. New Eng J Med 326: 298–304
Geha RS (1992) Regulation of IgE synthesis in humans. J Allergy Clin Immunol 90: 143–1
Madden KB, Urban JF Jr, Ziltener HJ, Schrader JW, Finkelman FD, Katona IM (1991) Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J Immunol 147: 1387–1391
Sanderson CJ (1992) Interleukin-5, eosinophils, and disease. Blood 79: 3101–3109
Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD (1996)Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nature Med 2: 449–456
Azzawi M, Bradley B, Jeffery PK, Frew AJ, Wardlaw AJ, Knowles G, Assoufi B, Collins JV, Durham S, Kay AB (1990) Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 142: 1407–1413
Bentley AM, Maestrelli P, Saetta M, Fabbri LM, Robinson DS, Bradley BL, Jeffery PK, Durham SR, Kay AB (1992) Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J Allergy Clin Immunol 89: 821–829
Kung TT, Stelts DM, Zurcher JA, Adams GK, Egan RW, Kreutner W, Watnick AS, Jones H, Chapman RW (1995) Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am J Respir Cell Mol Biol 13: 360–365
Nakajima H, Iwamoto I, Tomoe S, Matsumura R, Tomioka H, Takatsu K, Yoshida S (1992) CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 146: 374–377
Brusselle GG, Kips JC, Tavernier JH, Van der Heyden JG, Cuvelier CA, Pauwels RA, Bluethmann H (1994) Attenuation of allergic airway inflammation in IL-4 deficient mice.Clin Exp Allergy 24: 73–80
Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, Locksley RC (1996) Interleukin 4, but not interleukin 5 or eosinophils, is required in an acute model of airway hyperrreactivity. J Exp Med 183: 109–117
Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG (1996) Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.J Exp Med 183: 195–2
Snapper CM, Paul WE (1987) Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236: 944–947
Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lym-phokinesecretion lead to different functional properties. Ann Rev Immunol 7: 145–173
Yssel H, Schneider P, Spits H (1993) Production of IL-4 by human T cells and regulation of differentiation of T-cell subsets by IL-4. Res Immunol 144: 610–616
Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S (1993)Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177: 1199–1204
Seder RA, Gazzinelli R, Sher A, Paul WE (1993) Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci USA 90: 10188–10192
Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O’Garra A, Murphy KM (1993) Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547–549
Trinchieri G (1995)Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann Rev Immunol 13: 251–276
Alfonso LC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, Scott P (1994) The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263: 235–237
Miller MA, Skeen MJ, Ziegler HK (1995) Nonviable bacterial antigens administered with IL-12 generate antigen-specific T cell responses and protective immunity against Listeria monocytogenes. J Immunol 155: 4817–4828
Wynn TA, Cheever AW, Jankovic D, Poindexter RW, Caspar P, Lewis FA, Sher A (1995An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376: 594–596
Wynn TA, Reynolds A, James S, Cheever AW, Caspar P, Hieny S, Jankovic D, Strand M, Sher A (1996) IL-12 enhances vaccine-induced immunity to Schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. J Immunol 157: 4068–4078
Oswald IP, Caspar P, Jankovic D, Wynn TA, Pearce EJ, Sher A (1994) IL-12 inhibits Th2 cytokine responses induced by eggs of Schistosoma mansoni. J Immunol 153: 1707–1
Wang ZE, Zheng S, Corry DB, Dalton DK, Seder RA, Reiner SL, Locksley RM (1994) Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc Natl Acad Sci USA 91: 12932–12936
Marshall JD, Secrist H, DeKruyff RH, Wolf SF, Umetsu DT (1995) IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocytes. J Immunol 155: 111–117
Gavett SH, O’Hearn DJ, Li X, Huang SK, Finkelman FD, Wills-Karp M (1995) Inter-leukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 182: 1527–1536
Kips JC, Brusselle GJ, Joos GF, Peleman RA, Tavernier JH, Devos RR, Pauwels RA (1996) Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am Rev Respir Crit Care Med 153: 535–539
Sur S, Lam J, Bouchard P, Sigounas A, Holbert D, Metzger WJ (1996) Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses. J Immunol 157: 4173–4180
Mulligan RC (1993) The basic science of gene therapy. Science 260: 926–932
Sharma DP, Ramsay AJ, Maguire DJ, Rolph MS, Ramshaw IA (1996) Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. J Virol 70: 7103–7
Ramsay AJ, Husband AJ, Ramshaw IA, Bao S, Matthaei KI, Koehler G, Kopf M (1994) The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264: 561–
Ramshaw IA, Ramsay AJ, Karupiah G, Rolph MS, Mahalingam S, Ruby JC (1997) Cytokines and immunity to viral infection. Immunol Rev 159: 119–135
Coupar BEH, Andrew ME, Boyle DB (1988) A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes. Gene 68: 1–10
Sambrook J, Fritsch EF, Maniatis T (eds) (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press.
Andrew ME, Coupar BEH, Ada GL, Boyle DB (1986) Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants. Microb Pathog 1: 443–452
Lack G, Bradley KL, Hamelmann E, Renz H, Loader J, Leung DYM, Larsen G, Gelfand EW (1996) Nebulized IFN-γ inhibits the development of secondary allergic responses in mice. J Immunol 157: 1432–1439
Nakajima H, Iwamoto I, Yoshida S (1993) Aerosolized recombinant interferon-gamma prevents antigen-induced eosinophil recruitment in mouse trachea. Am Rev Respir Dis 148: 1102–1104
Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamigo R, Vilcek J, Zinkernagel R, Aguet M (1993) Immune response in mice that lack the interferon-γ receptor. Science 259: 1742–1745
Fujisawa T, Abu-Ghazaleh R, Kita H, Sanderson CJ, Gleich GJ (1990) Regulatory effects of cytokines on eosinophil degranulation. J Immunol 144: 642–646
Coleman JW, Morris AG (1991) Identification of a spleen cell-derived factor that inhibits sensitization of murine peritoneal mast cells as interferon-γ. Int Arch Allergy Appl Immunol 94: 179–180
Gauchat JF, Lebman DA, Coffman RL, Gascan H, De Vries J (1990) Structure and expression of germline e transcripts induced by interleukin-4 to switch to IgE production. J Exp Med 172: 463–473
Li X-M, Chopra RK, Chou T-Y, Schofield BH, Wills-Karp M, Huang S-K (1996) Mucosal IFN-γ gene transfer inhibits pulmonary allergic responses in mice. J Immunol 157: 3216–3219
Drazen JM, Arm JP, Austen KF (1996) Sorting out the cytokines of asthma. J Exp Med 183: 1–5
Ramsay AJ, Leong KH, Ramshaw IA (1997) DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunisation with DNA and viral vectors. Immunol Cell Biol 75: 382–388
Shaheen SO, Aaby P, Hall AJ, Barker D, Heyes C, Shiell AW, Goudiaby A (1996) Measles and atopy in Guinea-Bisau. Lancet 347: 1792–1796
Shirakawa T, Enomoto T, Shimazu S, Hopkin J (1997) The inverse association between tuberculin responses and atopic disorder. Science 275: 77–79
Bochner BS, Undem BJ, Lichtenstein LM (1994) Immunological aspects of allergic asthma. Ann Rev Immunol 12: 295–335
Lynch NR, Hagel I, Perez M, Di Prisco MC, Lopez R, Alvarez N (1993) Effect of anthelmintic treatment on the allergic reactivity of children in a tropical slum. J Allergy Clin Immunol 92: 404–411
Lacour M (1994) Acute infections in atopic dermatitis: a clue for a pathogenic role of a Th1/Th2 imbalance. Dermatology 188: 255–257
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Basel AG
About this chapter
Cite this chapter
Ramsay, A.J., Hogan, S.P., Foster, P.S., Xiong, Y. (2000). Cytokine gene therapy of allergic airways inflammation. In: Evans, C.H., Robbins, P.D. (eds) Gene Therapy in Inflammatory Diseases. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8478-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8478-5_5
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9584-2
Online ISBN: 978-3-0348-8478-5
eBook Packages: Springer Book Archive